Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Johannsson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Laeknabladid|July 5, 2018
[Opioid Induced Pituitary Dysfunction]Asta Isfold Jonasdottir, Jakob Johannsson, Mar Kristjansson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 11, 2009
Cost-effectiveness of human papilloma virus vaccination in IcelandKristjan Oddsson, Jakob Johannsson, Tinna Laufey Asgeirsdottir, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2023
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancerMartin P Nilsson, Christine Undseth, Per Albertsson, et al.
Plos Medicine|June 14, 2006
The BARD1 Cys557Ser variant and breast cancer risk in IcelandSimon N Stacey, Patrick Sulem, Oskar T Johannsson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2014
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO surveyYolande Lievens, Noémie Defourny, Mary Coffey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO surveyCai Grau, Noémie Defourny, Julian Malicki, et al.
Nature Genetics|April 29, 2008
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancerSimon N Stacey, Andrei Manolescu, Patrick Sulem, et al.
Nature Genetics|May 29, 2007
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancerSimon N Stacey, Andrei Manolescu, Patrick Sulem, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Laeknabladid|July 5, 2018
[Opioid Induced Pituitary Dysfunction]Asta Isfold Jonasdottir, Jakob Johannsson, Mar Kristjansson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 11, 2009
Cost-effectiveness of human papilloma virus vaccination in IcelandKristjan Oddsson, Jakob Johannsson, Tinna Laufey Asgeirsdottir, et al.
Acta Oncologica (Stockholm, Sweden)|July 28, 2023
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancerMartin P Nilsson, Christine Undseth, Per Albertsson, et al.
Plos Medicine|June 14, 2006
The BARD1 Cys557Ser variant and breast cancer risk in IcelandSimon N Stacey, Patrick Sulem, Oskar T Johannsson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2014
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO surveyYolande Lievens, Noémie Defourny, Mary Coffey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO surveyCai Grau, Noémie Defourny, Julian Malicki, et al.
Nature Genetics|April 29, 2008
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancerSimon N Stacey, Andrei Manolescu, Patrick Sulem, et al.
Nature Genetics|May 29, 2007
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancerSimon N Stacey, Andrei Manolescu, Patrick Sulem, et al.
Pageof 1